AbCellera Biologics (ABCL) Current Deferred Revenue (2020 - 2026)
AbCellera Biologics' Current Deferred Revenue came in at $20.71 million for Q2 2026, up 22.2% from $16.95 million a year earlier and up 167.4% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, AbCellera Biologics' Current Deferred Revenue was $13.53 million, unchanged from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $13.52 million in FY2024 (-28.7%), $18.96 million in FY2023 (-12.3%), $21.61 million in FY2022 (+186.8%) and $7.54 million in FY2021 (+14.4%).
- The Q2 2026 figure represents the highest quarterly Current Deferred Revenue since Q4 2022.
- Year-over-year, Current Deferred Revenue increased in four of the last eight quarters, with growth averaging 36.3%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q4 2022 (growth of 186.8%), and the weakest in Q3 2024 (a decline of 68.1%).
- Business Quant data shows ABCL's Current Deferred Revenue at $7.74 million (Q1 2026), $13.53 million (Q4 2025) and $15.69 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.71 Mn |
| Mar 31, 2026 | 7.74 Mn |
| Dec 31, 2025 | 13.53 Mn |
| Sep 30, 2025 | 15.69 Mn |
| Jun 30, 2025 | 16.95 Mn |
| Mar 31, 2025 | 18.79 Mn |
| Dec 31, 2024 | 13.52 Mn |
| Sep 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 18.96 Mn |
| Sep 30, 2023 | 17.51 Mn |
| Jun 30, 2023 | 8.54 Mn |
| Mar 31, 2023 | 11.81 Mn |
| Dec 31, 2022 | 21.61 Mn |
| Sep 30, 2022 | 6.82 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 9.19 Mn |
| Dec 31, 2021 | 7.54 Mn |
| Sep 30, 2021 | 6.17 Mn |
API Access
AbCellera Biologics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();